NCT01533558View on ClinicalTrials.gov

Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions
Invasive Fungal Infection
Interventions
DRUG

caspofungin

normal dosage for caspofungin, not adapted for the study

Trial Locations (4)

Unknown

Rijnstate Hospital, Arnhem

Canisius Wilhelmina Hospital (CWZ), Nijmegen

Radboud University Nijmegen Medical Centre, Nijmegen

University Medical Centre Utrecht, Utrecht

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01533558 - Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates | Biotech Hunter | Biotech Hunter